Our shot at the stars: Launching the Float Research Collective
The Float Conference 2022 :
In the summer of 2022, the Float Research Collective (FRC) was officially formed as a 501(c)(3) nonprofit organization. Its mission is to establish worldwide acceptance for Floatation-REST (Reduced Environmental Stimulation Therapy) as a treatment to naturally relieve pain, stress, anxiety and other related conditions. In this 2022 Float Conference presentation, the FRC President and Director, Dr. Justin Feinstein, unveils how the FRC will achieve this moonshot mission of getting floating accepted as a medical treatment, including a groundbreaking set of studies directly comparing Floatation-REST to the gold standard medical treatments for the rapid reduction of anxiety and pain, namely benzodiazepines and opioids.
Highly addictive drugs like Xanax (a benzo) and OxyContin (an opioid) have killed over 1 million Americans since the turn of the millennium due to drug overdoses.
Millions more are physiologically addicted to these prescription medications and unable to stop taking them without severe and often life-threatening withdrawal symptoms. In essence, our medical system has tried to medicate away society’s most ubiquitous forms of suffering using what has proven to be the most addictive substances on Earth. The FRC is challenging this whole backwards mentality that the only way to quickly relieve suffering is by popping a pill. The scientific research documenting floating’s rapid relief of both anxiety and pain provides a strong initial evidence base for pursuing these head-to-head clinical trials.



